These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31468739)

  • 1. Serum phosphatidylserine-specific phospholipase A
    Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y
    Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
    Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism.
    Nakawatari K; Kurano M; Araki O; Nishikawa M; Shimamoto S; Igarashi K; Aoki J; Murakami M; Yatomi Y
    Clin Chim Acta; 2020 Apr; 503():99-106. PubMed ID: 31978406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A
    Iwata Y; Kitajima S; Yamahana J; Shimomura S; Yoneda-Nakagawa S; Sakai N; Furuichi K; Ogura H; Sato K; Toyama T; Yamamura Y; Miyagawa T; Hara A; Shimizu M; Ohkawa R; Kurano M; Yatomi Y; Wada T
    Int J Rheum Dis; 2021 Feb; 24(2):231-239. PubMed ID: 33314787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
    Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma.
    Kurano M; Miyagaki T; Miyagawa T; Igarashi K; Shimamoto S; Ikeda H; Aoki J; Sato S; Yatomi Y
    J Dermatol; 2018 May; 45(5):571-579. PubMed ID: 29500864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
    Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
    Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
    Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
    Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study.
    Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R
    Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
    Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
    Front Immunol; 2021; 12():663192. PubMed ID: 34054830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
    El-Banna HS; El Khouly RM; Gado SE
    Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.
    Jin L; Weiqian C; Lihuan Y
    Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Serum β2-microglobulin in Egyptian Patients with Systemic Lupus Erythematosus.
    Abd-Elbaky NM; Albeltagy ES; Hammour AE; Ibrahim AS
    Egypt J Immunol; 2019 Jul; 26(2):143-153. PubMed ID: 31926503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
    Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
    Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus.
    Li H; Meng D; Jia J; Wei H
    Lipids Health Dis; 2021 Aug; 20(1):95. PubMed ID: 34461924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leucine-rich α2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.
    Ahn SS; Park Y; Jung SM; Song JJ; Park YB; Lee SW
    Clin Chim Acta; 2018 Nov; 486():253-258. PubMed ID: 30118672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.
    Roth DA; Thompson A; Tang Y; Hammer AE; Molta CT; Gordon D
    Lupus; 2016 Apr; 25(4):346-54. PubMed ID: 26385220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.